Central Serous Chorioretinopathy (CSC): Shedding an Evidence-Based Light on a Mysterious Disease

Welcome to the EURETINA Educational Webinar on Central Serous Chorioretinopathy (CSC), which took place on Thursday 7th October, 2021. During this 60-minute session, Camiel Boon (Leiden University Medical Centre, Netherlands) is joined by an international faculty of experts to discuss the diagnosis and management of CSC. The faculty includes Sekar Galuh (Leiden University Medical Center, Netherlands), Gemmy Cheung (Singapore National Eye Centre, Singapore), Elon Van Dijk (Leiden University Medical Center, Netherlands), Suzanne Yzer (Radboud UMC, Netherlands), and Sobha Sivaprasad (Moorfields Eye Hospital and University College, London, UK). Schedule 00:00 - 01:40 Introduction – Camiel J.F. Boon (NL) 01:40 - 08:30 Experimental evidence on CSC pathogenesis – Sekar Galuh (NL) 08:30 - 14:25 The choroid in CSC – Gemmy Cheung (SG) 14:25 - 21:40 Diagnosis of CSC – Elon Van Dijk (NL) 21:40 - 28:45 Differential diagnosis of CSC – Suzanne Yzer (NL) 28:45 - 37:45 Photodynamic therapy in CSC – Camiel J.F. Boon (NL) 36:45 - 45:00 Other treatments for CSC – Sobha Sivaprasad (GB) 45:00 - 60:21 Expert Panel Discussion – All Faculty Members can continue the discussion on the EURETINA Forum here: https://community.euretina.org/t/educ...

Central Serous Chorioretinopathy
▶︎

Central Serous Chorioretinopathy

Macular Degeneration: The Latest Science on Vision Improvement
▶︎

Macular Degeneration: The Latest Science on Vision Improvement

Gamma Knife stereotactic radiosurgery In the management of intracranial arteriovenous malformations
▶︎

Gamma Knife stereotactic radiosurgery In the management of intracranial arteriovenous malformations

What do tech pioneers think about the AI revolution? - The Engineers, BBC World Service
▶︎

What do tech pioneers think about the AI revolution? - The Engineers, BBC World Service

Clinical Case Discussions in Ocular Surface Disease with Dr. Laura McLaughlin
▶︎

Clinical Case Discussions in Ocular Surface Disease with Dr. Laura McLaughlin

Clinical Case Discussions: Qualified Autologous Serum Eye Drops (Q-ASEDs) in Ocular Surface Disease
▶︎

Clinical Case Discussions: Qualified Autologous Serum Eye Drops (Q-ASEDs) in Ocular Surface Disease

Ancient Human Species We Once Co-Existed With
▶︎

Ancient Human Species We Once Co-Existed With

ONLINE CONSULTATION-HOUR with Prof. Dr. Nicolas Feltgen
▶︎

ONLINE CONSULTATION-HOUR with Prof. Dr. Nicolas Feltgen

My Near Death Experience-Vinney Tolman
▶︎

My Near Death Experience-Vinney Tolman

My Shocking Diagnosis: MYOPIC MACULAR DEGENERATION
▶︎

My Shocking Diagnosis: MYOPIC MACULAR DEGENERATION

ABRC/CHER 2024 - Beyond BMI: Unraveling the Complexities of Weight, Stigma, and Care
▶︎

ABRC/CHER 2024 - Beyond BMI: Unraveling the Complexities of Weight, Stigma, and Care

UFO whistleblower Jake Barber would '100% testify' under oath to Congress | Reality Check
▶︎

UFO whistleblower Jake Barber would '100% testify' under oath to Congress | Reality Check

4 Groundbreaking New Treatments for Macular Degeneration in 2026
▶︎

4 Groundbreaking New Treatments for Macular Degeneration in 2026

Central Serous Chorioretinopathy Part 2
▶︎

Central Serous Chorioretinopathy Part 2

Age-Related Macular Degeneration: Current Treatments and Future Therapies
▶︎

Age-Related Macular Degeneration: Current Treatments and Future Therapies

How to Get Rid of Eye Floaters - Eye Floaters Treatment Explained
▶︎

How to Get Rid of Eye Floaters - Eye Floaters Treatment Explained

Rosacea: Presented by Prof Anne - Marie Tobin, Consultant Dermatologist
▶︎

Rosacea: Presented by Prof Anne - Marie Tobin, Consultant Dermatologist

Update on the Neurobiology of ADHD and implications for clinical practice by Prof Mark Bellgrove
▶︎

Update on the Neurobiology of ADHD and implications for clinical practice by Prof Mark Bellgrove

CSR-CSCR (central serous chorio retinopathy) - what is new?  by Dr. Sobha Sivaprasad
▶︎

CSR-CSCR (central serous chorio retinopathy) - what is new? by Dr. Sobha Sivaprasad

AI Is Creating A Rare Opportunity For Investors. How Jim Roppel Is Playing It. | Investing With IBD
▶︎

AI Is Creating A Rare Opportunity For Investors. How Jim Roppel Is Playing It. | Investing With IBD